Luttrell Applauds Trump Administration Move to Expand Neuroplastogen Research for Veterans

WASHINGTON - Congressman Morgan Luttrell (R-TX) issued the following statement in response to President Trump's Executive Order advancing federal research into the therapeutic potential of ibogaine:

"Today marks a decisive step forward in our commitment to exploring innovative treatments for the invisible wounds carried by so many of our veterans. I want to thank President Trump for his leadership on this issue and for recognizing the urgency of investing in groundbreaking research that will save lives.

Innovative therapies have shown life-changing results in treating combat-related mental health injuries, especially where conventional treatments, like opioids, have fallen short. If there's a chance to give our veterans their lives back, we have a responsibility to explore it.

For too long, outdated stigmas and bureaucratic hurdles have slowed progress in this space. This executive order signals a shift toward prioritizing results, evidence, and above all, the well-being of those who have sacrificed for our country. It is critical we give the men and women who have served this country every opportunity to recover and overcome these challenges.

I can personally attest to the significant benefits of this treatment. It changed my life, and I look forward to seeing the impact it will have on countless others. We're losing too many veterans. If this treatment gives us a chance to change that, then we owe it to them to pursue it. The President's executive order brings us closer to a lasting solution that our veterans deserve."